News

About 30% of patients with ulcerative colitis do not adequately respond to anti-TNF therapy.

The findings of this study can be applied to guide opioid counseling and monitoring when prescribing the medication.

The approved indication is a first-of-its-kind for a novel therapy—a bispecific antibody injection treatment for the leading causes of blindness.

A multitude of promising new investigative therapies are on the horizon for inherited retinal disease.

YOSEMITE and RHINE data further supports the novel agent for diabetic macular edema. A study investigators explains the impact of the new findings.

Dr. Modi discusses the pending approval of faricimab for nAMD, DME treatment and highlights important observations from phase 3 data.

Perspective from trial investigators and ophthalmologists on the novel drug, just prior to its potential FDA approval.

Outlook Therapeutics is expected to submit a BLA to the FDA for the investigative ophthalmic bevacizumab-vikg formulation (ONS-5010).

Oral CAIS had a slightly higher, but small risk of severe adverse reaction compared to topical CAIS, which may help the reluctance to prescribe.

Approximately 50% of individuals who commit suicide make a health care visit in the proceeding month.

Prior studies have predominantly considered the associations of respiratory allergy and skin allergy in patients with ADHD, with inconsistent data on food allergy.

Despite the prevalence of pulmonary exacerbations in patients with cystic fibrosis, there is no standardized definition to diagnose these events in affected patients.

There was not an association between sleep duration and metabolic diseases found in men.

A new study evaluated factors associated with quality of life by observing levels of chronic pain in Chinese patients who were receiving maintenance hemodialysis.

Dr. Swamy speaks of the history of burnout that preceded the pandemic, and how physicians are struggling with emotional, mental, and physical trauma from COVID-19.

Despite being the fastest growing racial group in the United States, Asian Americans have remained underrepresented in health disparities research.

Ineligible patients with schizophrenia have a higher risk of hospitalization for a number of reasons, including suicide attempts.

Significant associations between insomnia and race, sex, and psychiatric history were also observed.

A gene therapy for retinal degenerative diseases receives an investigational new drug (IND) clearance from the FDA to move forward with the Phase 2 trial of the multi-characteristic opsin (MCO-010) therapy.

Joined by 5 experts in the field of burnout, Crisis Point uncovers the ways burnout manifests and the ramifications it has on both personal and professional lives.

While reporting for race and ethnicity in US studies had increased from 59.8% to 71.9%, the proportion of articles including at least 20% non-White representation remained unchanged.

In the midst of a national blood crisis, the FDA is funding a study to examine if different questioning can be used to determine the HIV risk of gay or bisexual men who want to donate blood.

Investigators say that reducing COVID-19 hospitalizations among these groups will require partnerships among homeless services, correctional facilities and agencies, health care professionals, and public health agencies.

A better understanding of this connection could yield preventative treatments.

New findings from CDC data show three-fourths of all myocarditis cases observed in the first 8 months of COVID-19 vaccination occurred in persons 30 years and younger.

Take a Break was a 3-week interactive experience that involved motivational text messages, challenge quizzes, brief goal setting and more.

As the number of entecavir manufacturers increased from 1-11, the NADAC decreased from $30.12 to $1.93 per 0.5 mg tablet.